Medtech entrepreneurs: What do investors want?

Gallery

This gallery contains 1 photo.

This week I attended the 15th MedTech Investing Europe conference, in London. Around 35 fascinating companies presented or attended, looking for levels of investment ranging from £500k to £15 million. Two of the panels concentrated on investors – both VC … Continue reading

What makes a billion dollar medical devices man?

Gallery

This gallery contains 1 photo.

How do you know if you’re cut out to be a medical devices entrepreneur? While thinking about this question I came across the enlightening and fascinating story of Alfred Mann. Alfred Mann is a serial entrepreneur who has founded a … Continue reading

How virtual can your medtech startup be?

Gallery

This gallery contains 1 photo.

At least once a week I get drawn into a discussion about how virtual a medtech company can be – from its early stages right through to regulatory approval and even market launch. So, this post explores a few opportunities … Continue reading

Grow your competitive advantage through Khan Academy

Gallery

This gallery contains 1 photo.

“Mighty oaks from little acorns grow” As medtech specialists we spend our time working in a tough, competitive environment. Rewards are not distributed equally – the lions share goes to the winners, and the rest to everyone else. Are there … Continue reading

When Neopolitan Beats Vanilla: What Specialist Medtech Investors can Learn from Generalists

Gallery

This gallery contains 4 photos.

Many investors are specialists. Indeed, specialism in something is usually the way to excel at whatever is your choosing. But can it lead to challenges (e.g. tunnel vision), and is there a way to overcome the specialist’s curse? I’ve spent … Continue reading

15 Lessons from a Medtech Entrepreneur

Gallery

This gallery contains 3 photos.

Recently, I had the opportunity to meet a medtech entrepreneur building a company developing some fascinating and game-changing technology. The company is Ranier Technology based in Cambridge, UK and Dr Geoffrey Andrews is the founder and CEO. Ranier are developing … Continue reading

Lessons from Medtech?

Gallery

Investing in publicly listed life science companies versus early stage growth companies involves dealing with very different animals. But can we learn lessons from companies in the public markets? Perhaps, by considering factors that such investors deem important we can … Continue reading

Going against the Grain: Is it time to take a stand against “Asset Favoritism”?

Gallery

In his 2004 Chairman’s Letter at Berkshire Hathaway, Warren Buffet offered sound advice to those trying to find the best time to invest in equities: “be fearful when others are greedy and greedy when others are fearful”….But is going against the grain also a winning strategy for private equity investors in high-risk biotech ventures?
Continue reading

Is Pharma’s Perfect Storm Biotech’s Greatest Opportunity?

Gallery

Many folks within pharma lament the current challenges and look back to a gilded era when blockbusters provided rivers of cash flow and supported growth based activities – both R&D and marketing. And yet, could this present biotech’s greatest opportunity … Continue reading